Archean Chemical Industries Ltd
Archean Chemical Industries Q2 FY26 earnings call: Revenue & Margins
Q2 FY26 earnings call: what management said on revenue, margins and capex.
Guidance rank: #53 of 71 in Chemicals & Petrochemicals
See the sector's top 10 — free with your mobile number.
The short version
Archean expects robust growth in core businesses: industrial salt, bromine, and sulphate of potash (SOP). Core Business Growth: Continued focus on industrial salt, bromine, and sulphate of potash with expected volume growth and capacity utilization improvements driving revenue increases.
From Archean Chemical Industries Ltd's Q2 FY26 earnings-call transcript · updated 16 Oct 2026.
Revenue & Sales Performance
- Archean expects robust growth in core businesses: industrial salt, bromine, and sulphate of potash (SOP).
- Salt volumes to increase through new customers and expanded volumes, maintaining market leadership.
- Bromine capacity installed; focus to increase utilization rates to meet strong demand with price trends encouraging.
- SOP trials successful; commercial production expected post-monsoon FY '27 with potential to become a significant revenue driver.
- Bromine derivatives to play a larger role, increasing in utilization and product engagement.
- Oren Hydrocarbon ramp-up delayed but expected to contribute revenues starting FY '27.
2 more points from Archean Chemical Industries Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Archean Chemical Industries Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- INR 2,067 crore semiconductor capex for Phase 1 of a compound semiconductor fab in Odisha; includes government (Central and State) fiscal support (~60-65%) and Archean's contribution; timeline ~30 months post financial closure; focuses on 150 mm wafer line with involvement from Clas-SiC for technology and licensing.
- Bromine derivatives and Flame Retardant project: Capex of around INR 250 crores, with ~INR 190 crores already invested; Flame Retardant project expected online in 12-18 months.
- Energy storage investment: Acquired 18.14% stake in Offgrid Energy Labs (Zinc Bromide battery innovator); plan to invest further; Offgrid setting up 10 MWh pilot plant in the UK with intent to scale to giga-factory in 18-24 months.
- No significant capex planned for Oren Hydrocarbon and Acume beyond ongoing investments.
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Archean Chemical Industries Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- Archean Chemical Industries Limited currently has an order backlog of over 10,000 metric tons for bromine, indicating strong demand.
- The company aims to meet or exceed last year's bromine production volumes, suggesting ongoing robust order flow.
- For FY '26, the company is focusing on balancing pricing and volume to maintain margins without hampering salt volumes.
- The ramp-up in bromine derivatives and Oren Hydrocarbon products is expected to progress gradually, with meaningful revenue contributions anticipated from FY '27.
2 more points from Archean Chemical Industries Ltd's call on order book
Create a free account to keep reading this call
Archean Chemical Industries Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q1 FY27): revenue ₹327 Cr, net profit ₹30 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Archean Chemical Industries Ltd's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Gujarat Alkalies (Q2 FY26)
2,136.64 Crores (Page 21). Key investor presentation takeaways from Gujarat Alkalies & Chemicals Ltd's Q2 FY26 investor presentation — and how it ranks against
- Dynemic Products Ltd (Q2 FY26)
Quarterly revenue for Q2 FY 25-26: ₹8,935 lakhs (Page 12, 10, 5) . Key investor presentation takeaways from Dynemic Products's Q2 FY26 investor presentation — a
- Platinum Industries Ltd (Q2 FY26)
Q2FY26 Revenue from Operations (Consolidated): INR 983.8 Mn, down 1% YoY from INR 996.4 Mn in Q2FY25. Key investor presentation takeaways from Platinum Industri
- IVP Ltd (Q2 FY26)
Revenue from Operations for Q2FY26: ₹146.95 crores . Key investor presentation takeaways from IVP's Q2 FY26 investor presentation — and how it ranks against sec
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Archean Chemical Industries Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Archean Chemical Industries Ltd Q2 FY26 results?
Archean expects robust growth in core businesses: industrial salt, bromine, and sulphate of potash (SOP). Core Business Growth: Continued focus on industrial salt, bromine, and sulphate of potash with expected volume growth and capacity utilization improvements driving revenue increases.
What is Archean Chemical Industries Ltd share price analysis?
Archean Chemical Industries Ltd currently shows a neutral. The stock trades at a P/E of 61.0 with a market cap of ₹5,906 Cr. Investors should review the full earnings analysis for detailed insights.
Is Archean Chemical Industries Ltd planning capital expenditure?
INR 2,067 crore semiconductor capex for Phase 1 of a compound semiconductor fab in Odisha; includes government (Central and State) fiscal support (~60-65%) and Archean's contribution; timeline ~30 months post financial closure; focuses on 150 mm wafer line with involvement from Clas-SiC for technology and licensing.
Keep Archean Chemical Industries Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.